Nuformix (LSE:NFX) FCF Yield % : -18.08 (As of Apr. 13, 2025)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Nuformix's Trailing 12-Month Free Cash Flow is £-0.33 Mil, and Market Cap is £1.84 Mil. Therefore, Nuformix's FCF Yield % for today is -18.08%.

The historical rank and industry rank for Nuformix's FCF Yield % or its related term are showing as below:

LSE:NFX' s FCF Yield % Range Over the Past 10 Years
Min: -339.4 Med: -16.79 Max: -0.51
Current: -18.08

During the past 9 years, the highest FCF Yield % of Nuformix was -0.51%. The lowest was -339.40%. And the median was -16.79%.

LSE:NFX's FCF Yield % is ranked worse than
52.77% of 1499 companies
in the Biotechnology industry
Industry Median: -15.83 vs LSE:NFX: -18.08

Nuformix's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

Nuformix FCF Yield % Historical Data

The historical data trend for Nuformix's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix FCF Yield % Chart

Nuformix Annual Data

Trend

Dec15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Sep24

FCF Yield %

Get a 7-Day Free Trial

-3.88

-6.36

-22.43

-19.69

-68.68

Nuformix Semi-Annual Data
	Dec15	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Mar24	Sep24
FCF Yield %	Get a 7-Day Free Trial												-24.92	-26.47	-8.64	-21.71	-67.44

Competitive Comparison of Nuformix's FCF Yield %

For the Biotechnology subindustry, Nuformix's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuformix's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuformix's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Nuformix's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Nuformix FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Nuformix's FCF Yield % for the fiscal year that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.332	/	0.48339231
	=	-68.68%

Nuformix's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.163	*	2	/	0.48339231
	=	-67.44%

Nuformix FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Nuformix FCF Yield % Related Terms

Thank you for viewing the detailed overview of Nuformix's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.